Ligo Analytics, Inc

Dialectic Therapeutics, Inc. is a Dallas-based biotechnology company dedicated to developing innovative anti-cancer therapies aimed at improving the lives of patients with limited treatment options. Founded by esteemed cancer scientists and experienced biotech investors, the company focuses on creating targeted treatments with reduced toxicities through its novel APTaD platform. The company's lead candidate, DT2216, is designed to selectively induce cancer cell death by targeting the BCL-XL protein, demonstrating effectiveness in both liquid and solid tumors with minimal toxicity. With a team comprising experts in protein degradation and clinical development, Dialectic Therapeutics is committed to addressing high unmet needs in late-stage cancer treatment. Generated from the website

Lantern Pharma Inc, based in Dallas, Texas, is a biotechnology company focused on the development of cancer therapeutics. The company collaborates with international partners, such as Oncology Venture A/S, to advance clinical projects and secure funding for innovative drug development. Through strategic agreements and grants, including support from the Massachusetts Life Sciences Center, Lantern Pharma aims to enhance the efficacy and accessibility of its cancer treatments. Their ongoing projects reflect a commitment to leveraging collaborative industry programs to drive advancements in oncology. Generated from their business information